UNSPSC 51132224: Acetaminophen/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51132224 Acetaminophen/salicylamide is a Commodity code that in recent state and local procurement activity covers a broader range of pharmaceutical products and direct-to-manufacturer prescription fulfillment arrangements than the code name alone suggests. State and local buyers—including county health departments, state health and human services commissions, and cooperative purchasing alliances—are soliciting naloxone and drug deactivation systems for community health initiatives, generic multi-source pharmaceuticals and over-the-counter products through wholesaler distribution networks, and exploring direct-to-manufacturer prescription programs to manage costs and improve fulfillment efficiency. The scope spans both finished pharmaceutical goods and the contracting infrastructure needed to support them, with vendors expected to meet cGMP and Drug Supply Chain Security Act compliance, maintain specified insurance coverage, and in some cases establish direct relationships with state agencies outside traditional pharmacy benefit manager and group purchasing organization channels.

Recent activity shows solicitations from Florida county health departments, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance serving multiple jurisdictions including Oregon. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas HHS Commission posted a Request for Information (HHS0017013, due April 3, 2026) to gather vendor capabilities on implementing direct-to-manufacturer prescription programs outside traditional PBM and GPO arrangements. MMCAP issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awarded vendors to be provided to authorized wholesalers by May 15, 2026 and contracts effective July 1, 2026; evaluation weighted price competitiveness at 75 percent and required vendors to maintain two of three authorized wholesaler relationships with chargeback systems in place. The code shows activity concentrated in the Southeast and Upper Midwest, with broader multi-state reach through cooperative purchasing vehicles.